(firstQuint)A Study of Pharmacokinetic Comparison of Two Recombinant Exendin-4 Formulations in Chinese Healthy Male Subjects.

 The study design is an Open-Label Randomized, Single-Dose, 2-way Crossover Bioequivalence Study with a washout period of 7 days.

 During each session, the subjects will receive a subcutaneous single dose of rE-4 (rE-4 Injection 10 mu g or rE-4 Freeze-dried Powder 10 mu g) administered 30min prior to the start time of a standard breakfast.

.

 A Study of Pharmacokinetic Comparison of Two Recombinant Exendin-4 Formulations in Chinese Healthy Male Subjects@highlight

Evaluation of the pharmacokinetics and safety rE-4 Injection versus rE-4 Freeze-dried Powder in healthy subjects.

